牛診断薬市場規模・予測（2020年～2030年）、世界・地域シェア、動向、成長機会分析レポート対象範囲製品別（免疫測定キット、PCR試薬＆キット、凝集沈降阻止（HI）アッセイ、その他製品）、疾病タイプ別（牛ウイルス性下痢症（BVD）、牛結核（TB）、牛乳房炎、口蹄疫（FMD）、その他疾病タイプ）、エンドユーザー別（動物病院、動物病院クリニック、その他エンドユーザー）、地域別

Bovine Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography

牛の診断薬市場規模は、2022年の11億5,559万米ドルから2030年には20億1,115万米ドルに達すると予測され、2022年から2030年までの年平均成長率は7.2%を記録すると予測されている。継続的な研究開発努力により... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年9月6日	US$4,550 シングルユーザライセンスライセンス・価格情報注文方法はこちら	152	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

牛の診断薬市場規模は、2022年の11億5,559万米ドルから2030年には20億1,115万米ドルに達すると予測され、2022年から2030年までの年平均成長率は7.2%を記録すると予測されている。

継続的な研究開発努力により、動物用診断薬企業は迅速な結果を提供する様々な革新的診断薬を発売している。さらに、政府による教育プログラムや知識共有プログラムを通じてエンドユーザーの意識が高まっていることも、各社が先進的な診断製品を導入する後押しとなっている。牛用診断薬市場における最近の製品発表の一部を以下に示す。

- 2023年6月、Zoetis, Inc.は、次の搾乳の8時間前に結果を提供する農場での乳房炎診断ソリューション、Vetscan Mastigram+を発売した。Vetsacn Mastigram+は牛のグラム陽性乳房炎を検出するためにフローディップスティックテストを使用する。この製品は、99％の感度と100％の特異性で、グラム陽性菌とグラム陰性菌を区別し、牛乳中のグラム陽性病原体の存在を検出する。

- 2023年6月、ネオジェン・コーポレーションは乳牛用のDNA検査であるIgenity^ BeefXDairyを発売した。この検査は、枝肉品質、平均日増体、Igenity Terminal Indexなどの形質に関する洞察を生産者に提供する。さらに、バイヤーが牛の健康管理を最適化し、牛の製品収量を最大化するのに役立つ品種構成データを受け取ることができる。

- 2023年8月、スコットランドのバイオテクノロジー企業であるバイオタンジェンツは、次世代分子診断アッセイAmpliSpec LAB Mastitisの発売を発表した。同社は、アンプリスペックLAB乳房炎は乳牛の乳房炎病原体を検出する感度93％、特異度95％の高度に洗練されたアッセイであるとしている。

口蹄疫の増加が牛診断薬市場の成長を押し上げる可能性が高い

家畜では、口蹄疫（FMD）は感染力の強いウイルス性疾患で、経済的に大きな影響を与える。牛、豚、羊、山羊、その他の蹄を持つ反芻動物が罹患する。この病気は越境性動物疾病（TAD）であり、地域および世界市場における動物と畜産物の取引を混乱させる。世界動物保健機構によると、アフリカ、中東、アジア、南米の限られた地域を中心に、家畜の77％がこの病気に感染していると推定されている。FMDの予防と対策にかかる費用の合計75％は、所得の低い国や中流以下の国によって賄われている。総コストの約50％はアフリカとユーラシア大陸が負担している。アフタウイルスの7つの株（A、O、C、SAT1、SAT2、SAT3、アジア1）が世界各地で流行している。FMDの予防は、早期発見・警報システム、効果的なサーベイランス、その他の対策に基づいている。ワクチン接種を受けた動物が免疫を獲得するには、各系統に特有のワクチンが必要です。

最も一般的なFMD診断技術は、FMDウイルス抗原、ウイルス分離、中和を検出する感染関連抗原（VIA）、補体固定（CF）、ELISA、PCR検査です。IDEXX では、ウシ由来の血清または血漿検体中の FMDV に対する抗体を検出するための酵素免疫測定法、IDEXX FMD 3 ABC Ab テストキットを提供しています。

このように、前述の要因が口蹄疫セグメントの牛診断薬市場の成長を後押ししている。

レポートのセグメント化

牛診断薬の世界市場」は、製品、疾病タイプ、エンドユーザーに基づいてセグメント化されている。

製品別では、牛診断薬市場はイムノアッセイキット、PCRキット、血球凝集阻害（HI）アッセイ、その他に二分される。2022年の市場シェアはイムノアッセイキットが大きく、2022-2030年のCAGRもイムノアッセイキットが上回ると予測されている。

疾病タイプに基づき、市場は牛ウイルス性下痢（BVD）、牛結核（TB）、牛乳房炎、口蹄疫（FMD）、その他に分類される。牛乳房炎セグメントは2022年に大きな市場シェアを占め、このセグメントは2022-2030年に高いCAGRを記録すると予測されている。

エンドユーザー別に見ると、牛診断市場は動物病院、動物診療所、その他に分けられる。動物病院セグメントは2022年に大きな市場シェアを占め、同セグメントは2022-2030年に高いCAGRを記録すると予測されている。

牛診断薬市場で事業を展開している主な企業は、Idexx Laboratories Inc、PBD Biotech Ltd、Thermo Fisher Scientific Inc、Innovative Diagnostics SAS、Neogen Corp、Enfer Labs、bioMerieux SA、Ring Biotechnology Co Ltd、Bionote Inc、Shenzhen Bioeasy Biotechnology Co Ltdである。

American Association for Thoracic Surgery (AATS)、Centers for Disease Control and Prevention (CDC)、National Institute for Health and Care Excellence (NICE)、Organisation for Economic Co-operation and Development (OECD)、Spanish National Health System (SNS)などは、牛の診断薬市場に関するレポートを作成する際に参照した主要な一次情報源および二次情報源です。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Bovine Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Regulatory Scenario
4.4.1 Definitions
4.4.2 FDA Regulatory Requirements for Animal Health Devices
4.4.3 European Union’s Veterinary Medicinal Products Regulation
5. Bovine Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 High Prevalence and Economic Impact of Bovine Mastitis
5.1.2 Increasing Number of Product Launches
5.2 Key Market Restraints:
5.2.1 Lack of Skilled Professionals in Veterinary Research
5.3 Key Market Opportunities:
5.3.1 High Prevalence of Bovine Tuberculosis
5.4 Future Trends
5.4.1 Upsurge in Research Funding to Develop Modern Diagnostic Approaches
5.5 Impact Analysis:
6. Bovine Diagnostics Market - Global Market Analysis
6.1 Bovine Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Global Bovine Diagnostics Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Bovine Diagnostics Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Immunoassay Kits
7.3.1 Overview
7.3.2 Immunoassay Kits: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 PCR Kits
7.4.1 Overview
7.4.2 PCR Kits: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Hemagglutination Inhibition (HI) Assay
7.5.1 Overview
7.5.2 Hemagglutination Inhibition (HI) Assay: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Bovine Diagnostics Market – Revenue and Forecast to 2030 – by Disease Type
8.1 Overview
8.2 Bovine Diagnostics Market Revenue Share, by Disease Type 2022 & 2030 (%)
8.3 Bovine Viral Diarrhea (BVD)
8.3.1 Overview
8.3.2 Bovine Viral Diarrhea (BVD): Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Bovine Tuberculosis (TB)
8.4.1 Overview
8.4.2 Bovine Tuberculosis (TB): Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Bovine Mastitis
8.5.1 Overview
8.5.2 Bovine Mastitis: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Foot and Mouth Disease (FMD)
8.6.1 Overview
8.6.2 Foot and Mouth Disease (FMD): Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Bovine Diagnostics Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Bovine Diagnostics Market Revenue Share, by end user 2022 & 2030 (%)
9.3 Veterinary Hospitals
9.3.1 Overview
9.3.2 Veterinary Hospitals: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Veterinary Clinics
9.4.1 Overview
9.4.2 Veterinary Clinics: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Bovine Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Bovine Diagnostics Market - Geographical Analysis
10.1 North America Bovine Diagnostics Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.1 North America Bovine Diagnostics Market, by Product
10.1.2.2 North America Bovine Diagnostics Market, by Disease Type
10.1.2.3 North America Bovine Diagnostics Market, by End User
10.1.2.4 North America Bovine Diagnostics Market, by Country
10.1.2.5 US
10.1.2.5.1 Overview
10.1.2.5.2 US Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.5.3 US Bovine Diagnostics Market, by Product
10.1.2.5.4 US Bovine Diagnostics Market, by Disease Type
10.1.2.5.5 US Bovine Diagnostics Market, by End User
10.1.2.6 Canada
10.1.2.6.1 Overview
10.1.2.6.2 Canada Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.6.3 Canada Bovine Diagnostics Market, by Product
10.1.2.6.4 Canada Bovine Diagnostics Market, by Disease Type
10.1.2.6.5 Canada Bovine Diagnostics Market, by End User
10.1.2.7 Mexico
10.1.2.7.1 Overview
10.1.2.7.2 Mexico Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.7.3 Mexico Bovine Diagnostics Market, by Product
10.1.2.7.4 Mexico Bovine Diagnostics Market, by Disease Type
10.1.2.7.5 Mexico Bovine Diagnostics Market, by End User
10.2 Europe Bovine Diagnostics Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.1 Europe Bovine Diagnostics Market, by Product
10.2.2.2 Europe Bovine Diagnostics Market, by Disease Type
10.2.2.3 Europe Bovine Diagnostics Market, by End User
10.2.2.4 Europe Bovine Diagnostics Market, by Country
10.2.2.5 UK
10.2.2.5.1 Overview
10.2.2.5.2 UK Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.5.3 UK Bovine Diagnostics Market, by Product
10.2.2.5.4 UK Bovine Diagnostics Market, by Disease Type
10.2.2.5.5 UK Bovine Diagnostics Market, by End User
10.2.2.6 Germany
10.2.2.6.1 Overview
10.2.2.6.2 Germany Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.6.3 Germany Bovine Diagnostics Market, by Product
10.2.2.6.4 Germany Bovine Diagnostics Market, by Disease Type
10.2.2.6.5 Germany Bovine Diagnostics Market, by End User
10.2.2.7 France
10.2.2.7.1 Overview
10.2.2.7.2 France Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.7.3 France Bovine Diagnostics Market, by Product
10.2.2.7.4 France Bovine Diagnostics Market, by Disease Type
10.2.2.7.5 France Bovine Diagnostics Market, by End User
10.2.2.8 Italy
10.2.2.8.1 Overview
10.2.2.8.2 Italy Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.8.3 Italy Bovine Diagnostics Market, by Product
10.2.2.8.4 Italy Bovine Diagnostics Market, by Disease Type
10.2.2.8.5 Italy Bovine Diagnostics Market, by End User
10.2.2.9 Spain
10.2.2.9.1 Overview
10.2.2.9.2 Spain Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.9.3 Spain Bovine Diagnostics Market, by Product
10.2.2.9.4 Spain Bovine Diagnostics Market, by Disease Type
10.2.2.9.5 Spain Bovine Diagnostics Market, by End User
10.2.2.10 Rest of Europe
10.2.2.10.1 Overview
10.2.2.10.2 Rest of Europe Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.2.2.10.3 Rest of Europe Bovine Diagnostics Market, by Product
10.2.2.10.4 Rest of Europe Bovine Diagnostics Market, by Disease Type
10.2.2.10.5 Rest of Europe Bovine Diagnostics Market, by End User
10.3 Asia Pacific Bovine Diagnostics Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.1 Asia Pacific Bovine Diagnostics Market, by Product
10.3.2.2 Asia Pacific Bovine Diagnostics Market, by Disease Type
10.3.2.3 Asia Pacific Bovine Diagnostics Market, by End User
10.3.2.4 Asia Pacific Bovine Diagnostics Market, by Country
10.3.2.5 China
10.3.2.5.1 Overview
10.3.2.5.2 China Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.5.3 China Bovine Diagnostics Market, by Product
10.3.2.5.4 China Bovine Diagnostics Market, by Disease Type
10.3.2.5.5 China Bovine Diagnostics Market, by End User
10.3.2.6 Japan
10.3.2.6.1 Overview
10.3.2.6.2 Japan Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.6.3 Japan Bovine Diagnostics Market, by Product
10.3.2.6.4 Japan Bovine Diagnostics Market, by Disease Type
10.3.2.6.5 Japan Bovine Diagnostics Market, by End User
10.3.2.7 India
10.3.2.7.1 Overview
10.3.2.7.2 India Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.7.3 India Bovine Diagnostics Market, by Product
10.3.2.7.4 India Bovine Diagnostics Market, by Disease Type
10.3.2.7.5 India Bovine Diagnostics Market, by End User
10.3.2.8 South Korea
10.3.2.8.1 Overview
10.3.2.8.2 South Korea Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.8.3 South Korea Bovine Diagnostics Market, by Product
10.3.2.8.4 South Korea Bovine Diagnostics Market, by Disease Type
10.3.2.8.5 South Korea Bovine Diagnostics Market, by End User
10.3.2.9 Australia
10.3.2.9.1 Overview
10.3.2.9.2 Australia Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.9.3 Australia Bovine Diagnostics Market, by Product
10.3.2.9.4 Australia Bovine Diagnostics Market, by Disease Type
10.3.2.9.5 Australia Bovine Diagnostics Market, by End User
10.3.2.10 Rest of Asia Pacific
10.3.2.10.1 Overview
10.3.2.10.2 Rest of Asia Pacific Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.3.2.10.3 Rest of Asia Pacific Bovine Diagnostics Market, by Product
10.3.2.10.4 Rest of Asia Pacific Bovine Diagnostics Market, by Disease Type
10.3.2.10.5 Rest of Asia Pacific Bovine Diagnostics Market, by End User
10.4 Middle East & Africa Bovine Diagnostics Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.1 Middle East & Africa Bovine Diagnostics Market, by Product
10.4.2.2 Middle East & Africa Bovine Diagnostics Market, by Disease Type
10.4.2.3 Middle East & Africa Bovine Diagnostics Market, by End User
10.4.2.4 Middle East & Africa Bovine Diagnostics Market, by Country
10.4.2.5 Saudi Arabia
10.4.2.5.1 Overview
10.4.2.5.2 Saudi Arabia Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.5.3 Saudi Arabia Bovine Diagnostics Market, by Product
10.4.2.5.4 Saudi Arabia Bovine Diagnostics Market, by Disease Type
10.4.2.5.5 Saudi Arabia Bovine Diagnostics Market, by End User
10.4.2.6 South Africa
10.4.2.6.1 Overview
10.4.2.6.2 South Africa Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.6.3 South Africa Bovine Diagnostics Market, by Product
10.4.2.6.4 South Africa Bovine Diagnostics Market, by Disease Type
10.4.2.6.5 South Africa Bovine Diagnostics Market, by End User
10.4.2.7 UAE
10.4.2.7.1 Overview
10.4.2.7.2 UAE Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.7.3 UAE Bovine Diagnostics Market, by Product
10.4.2.7.4 UAE Bovine Diagnostics Market, by Disease Type
10.4.2.7.5 UAE Bovine Diagnostics Market, by End User
10.4.2.8 Rest of Middle East & Africa
10.4.2.8.1 Overview
10.4.2.8.2 Rest of Middle East & Africa Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.4.2.8.3 Rest of Middle East & Africa Bovine Diagnostics Market, by Product
10.4.2.8.4 Rest of Middle East & Africa Bovine Diagnostics Market, by Disease Type
10.4.2.8.5 Rest of Middle East & Africa Bovine Diagnostics Market, by End User
10.5 South & Central America Bovine Diagnostics Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.1 South & Central America Bovine Diagnostics Market, by Product
10.5.2.2 South & Central America Bovine Diagnostics Market, by Disease Type
10.5.2.3 South & Central America Bovine Diagnostics Market, by End User
10.5.2.4 South & Central America Bovine Diagnostics Market, by Country
10.5.2.5 Brazil
10.5.2.5.1 Overview
10.5.2.5.2 Brazil Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.5.3 Brazil Bovine Diagnostics Market, by Product
10.5.2.5.4 Brazil Bovine Diagnostics Market, by Disease Type
10.5.2.5.5 Brazil Bovine Diagnostics Market, by End User
10.5.2.6 Argentina
10.5.2.6.1 Overview
10.5.2.6.2 Argentina Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.6.3 Argentina Bovine Diagnostics Market, by Product
10.5.2.6.4 Argentina Bovine Diagnostics Market, by Disease Type
10.5.2.6.5 Argentina Bovine Diagnostics Market, by End User
10.5.2.7 Rest of South & Central America
10.5.2.7.1 Overview
10.5.2.7.2 Rest of South & Central America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
10.5.2.7.3 Rest of South & Central America Bovine Diagnostics Market, by Product
10.5.2.7.4 Rest of South & Central America Bovine Diagnostics Market, by Disease Type
10.5.2.7.5 Rest of South & Central America Bovine Diagnostics Market, by End User
11. Pre & Post Covid-19 Impact
11.1 Pre & Post Covid-19 Impact
12. Bovine Diagnostics Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 Idexx Laboratories Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 PBD Biotech Ltd
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Innovative Diagnostics SAS
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Neogen Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Enfer Labs
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 bioMerieux SA
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Ring Biotechnology Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Bionote Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Shenzhen Bioeasy Biotechnology Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The bovine diagnostics market size is expected to reach US$ 2,011.15 million by 2030 from US$ 1,155.59 million in 2022; it is estimated to record a CAGR of 7.2% from 2022 to 2030.

Continuous research and development efforts allow veterinary diagnostics companies to launch various innovative diagnostics products that provide rapid results. In addition, growing awareness among end users through the government’s educative and knowledge-sharing programs has encouraged these companies to introduce advanced diagnostics products. A few of the recent product launches in the bovine diagnostics market have been mentioned below.

• In June 2023, Zoetis, Inc. launched Vetscan Mastigram+, an on-farm mastitis diagnostic solution that provides results 8 hours before the next milking. The Vetsacn Mastigram+ uses a flow dipstick test to detect Gram-positive mastitis in cattle. The product would detect the presence of Gram-positive pathogens in cow milk with 99% sensitivity and 100% specificity, along with differentiating between for Gram-positive and Gram-negative bacteria.

• In June 2023, Neogen Corporation launched Igenity^ BeefXDairy, a DNA test for beef-on-dairy cattle. The test would provide insights into the traits such as carcass quality, average daily gain, and the Igenity Terminal Index to the producers. In addition, it would allow buyers to receive breed composition data to help them with optimal cattle health management and maximize the cattle product yield.

• In August 2023, Biotangents, a Scottish biotech company, announced the launch of its next-generation molecular diagnostic assay—AmpliSpec LAB Mastitis. The company claims that AmpliSpec LAB Mastitis is a highly sophisticated assay with 93% sensitivity and 95% specificity in detecting mastitis pathogens in dairy cows.

Increasing incidences of foot and mouth diseases are likely to boost the growth of bovine diagnostics market

In livestock, foot and mouth disease (FMD) is a highly contagious viral disease that has a significant economic impact. It affects cattle, swine, sheep, goats, and other cloven-hoofed ruminants. The disease is a transboundary animal disease (TAD) that disrupts the trade of animals and animal products in regional and global markets. According to the World Organization for Animal Health, 77% population of livestock is estimated to be infected with the disease across the world, primarily in Africa, the Middle East, and Asia, as well as a limited area of South America. A total of 75% of FMD prevention and control costs are provided by countries with low incomes and lower middle incomes. Approximately 50% of the total costs are incurred by Africa and Eurasia. Seven strains of an Aphthovirus (A, O, C, SAT1, SAT2, SAT3, and Asia1) are endemic in different parts of the world. The prevention of FMD is based on early detection and warning systems, effective surveillance, and other measures. Each strain requires a specific vaccine to provide immunity to a vaccinated animal.

Most common FMD diagnostic techniques are infection-associated antigen (VIA), complement fixation (CF), ELISA, and PCR tests to detect FMD viral antigen, virus isolation, and neutralization. IDEXX offers IDEXX FMD 3 ABC Ab Test Kit, an enzyme immunoassay for the detection of antibodies against FMDV in serum or plasma samples of bovine origin.

Thus, aforementioned factors propel the bovine diagnostics market growth for the foot and mouth disease segment.

Report Segmentation:

The “Global Bovine Diagnostics Market” is segmented based on product, disease type, and end user.

By product, the bovine diagnostics market is bifurcated into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assay, and others. The immunoassay kits segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR during 2022–2030.

Based on disease type, the market is categorized into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The bovine mastitis segment held a larger market share in 2022 and the segment is anticipated to register a higher CAGR during 2022–2030.

Based on end user, the bovine diagnostics market is divided into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022–2030.

Major players operating in the bovine diagnostics market are Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd.

The American Association for Thoracic Surgery (AATS), Centers for Disease Control and Prevention (CDC), National Institute for Health and Care Excellence (NICE), Organisation for Economic Co-operation and Development (OECD), and Spanish National Health System (SNS) among others are a few key primary and secondary sources referred to while preparing the report on the bovine diagnostics market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（diagnostics）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療機器）の最新刊レポート

The Insight Partners 社の最新刊レポート

本レポートと同じKEY WORD（diagnostics）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?